Previous Article | Next Article ![]()
Infection and Immunity, April 2007, p. 1861-1869, Vol. 75, No. 4
0019-9567/07/$08.00+0 doi:10.1128/IAI.01473-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Biotechnology, Hoseo University, Chungnam, South Korea,1 Division of Life Science, College of Natural Sciences, Gyeongsang National University, Chinju, South Korea2
Received 14 September 2006/ Returned for modification 5 November 2006/ Accepted 22 January 2007
|
|
|---|
|
|
|---|
Over the last 2 decades, enterococci have been recognized as being among the most common hospital-acquired pathogens causing a wide variety of diseases in humans. This class of pathogens can infect the bloodstream (3), urinary tract (15), endocardium (34), and biliary tract as well as burn wounds (23) and periodontal tissues (26). In addition, as enterococci are frequently isolated from polymicrobial flora (8, 37), the enterococci have been theorized to play a role in bacterial synergy (32, 33). Despite increasing recognition of the clinical importance of enterococcal infections, the pathogenic mechanisms utilized by this class of pathogens remain unclear. Among diverse enterococcal species, Enterococcus faecalis is known to be most responsible for enterococcal infections (23). E. faecalis has been reported to generate a variety of factors important for virulence, including aggregation substance (14), sex pheromones (42), cytolysin (5), hyaluronidase (26), MSCRAMM protein (40), and extracellular proteases (gelatinase and serine protease) (11), although the virulence mechanisms inherent to these factors also remain largely unknown. Gelatinase (GelE), which is the major interest of this study, was proposed to have an important role in biofilm formation (7, 17) and translocation of bacteria across intestinal cell layers (52). However, there are also still debates on the exact mechanism for the virulence activity of GelE.
Recently, we have isolated E. faecalis from the body fluids of dead G. mellonella larvae and have purified a GelE protein as an insecticidal toxin from E. faecalis culture media. The purified GelE protein was determined to be 99% identical to previously known E. faecalis GelE with regard to its amino acid sequence. Some bacterial proteases, such as elastases of Pseudomonas aeruginosa, have been reported to exert their virulence effects via altering host immune response (2, 41). We have thus performed a series of experiments to elucidate the relationship between E. faecalis GelE and the host immune system. We first evaluated the insecticidal activity of the purified GelE protein against G. mellonella larvae and also investigated the effect of GelE on the defense system of the hemolymph. The results from other previous works about P. aeruginosa elastase and the results from our work performed with a G. mellonella infection model led us to postulate that GelE may perform a critical role in the pathogenesis of enterococcal infection in human blood. Accordingly, we attempted to determine whether or not E. faecalis GelE affects the complement system and inhibits the immune reactions resultant from complement activation. To the best of our knowledge, this is the first paper to identify and describe the virulence mechanism of E. faecalis GelE in human serum.
|
|
|---|
Infection and survival experiments. Enterococcus faecalis ATCC 51299, which was a human isolate, was selected as a control strain in this experiment. Galleria mellonella larvae were injected with washed mid-logarithmic-phase E. faecalis GM or E. faecalis ATCC 51299 (5 x 105 cells per larva) in 5 µl of autoclaved 10 mM sodium phosphate (NaP) buffer at a pH of 7.4. The test group used for infection by each of the bacterial strains consisted of 100 insects, and insect mortality was monitored at 6-h intervals for the first 24 h and then at 4-h intervals. In addition, 5 µl of a concentrate of the E. faecalis GM or ATCC 51299 culture supernatant (CS) containing 20 µg of proteins was injected into the hemocoel of each of 10 larvae. The CS of each E. faecalis strain was concentrated via ultrafiltration, using a 10-kDa cutoff membrane (Vivaflow 200, no. 05VF20045; Vivascience Ltd., United Kingdom) and adjusted to the same concentration. Alternatively, the concentrated CS of E. faecalis GM was heated for 5 min at 75°C, and the same amount of heat-treated sample was injected into each insect. As the injection of the concentrated CS of E. faecalis GM into the G. mellonella larvae resulted in rapid death of insects, the mortality of the insects was assessed at 5-min intervals.
Purification of GelE from concentrated CS of E. faecalis GM.
The culture of E. faecalis GM was centrifuged for 30 min at 10,000 x g. A 3-liter sample of cell-free CS was concentrated to
20 ml as described above. The concentrated CS was loaded onto a Sephadex G-100 column (2.5 by 70 cm) equilibrated with NaP buffer. Fractions were eluted at a flow rate of 6 ml/h and collected at intervals of 20 min. Every second fraction was assessed with regard to its insecticidal activity, in accordance with the following procedure. First, 50 µl of fraction was dried with a vacuum centrifugation system (Centra evaporator; Bioneer, Daejon, Korea) and resuspended in 6 µl of distilled water. Then, 5 µl was removed and injected into a G. mellonella larva. Five larvae were used for each test fraction. Fractions resulting in 100% insect mortality after overnight rearing were pooled and concentrated to
10 ml by ultrafiltration. The sample was then applied to a DEAE anion exchange column (SOURCE 15Q; Amersham Biosciences, Uppsala, Sweden). After sample injection, the column was washed with NaP buffer containing 50 mM NaCl. Then, the NaCl concentration was increased in a linear fashion up to 500 mM for 50 min, and the eluted fractions were collected in peak mode. Each fraction of two peaks was then concentrated with a Vivaspin concentrator equipped with a 10-kDa cutoff membrane and subjected to tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). To test the insecticidal activity of each of the purified proteins, the 5-µl samples, harboring various amounts of protein, were injected into G. mellonella larvae, after which insect mortality was monitored at the predetermined postinjection time. Ten larvae were used for each of the test groups. The N-terminal amino acid sequences of two purified proteins were determined via gas phase Edman degradation at the Korea Basic Science Institute. As described in Results, it was determined that the protein in the first peak was E. faecalis GelE, and the second peak was identified as a serine protease (SprE). In order to generate antibodies against GelE, the purified GelE was heat inactivated for 5 min at 75°C, as the injection of fresh GelE resulted in severe damage to the rabbit. According to conventional procedure, antiserum was taken 1 week after the booster injection of heat-inactivated antigen and employed in the immunoblot analysis (50). A 1,000-fold-diluted antiserum was used in this experiment.
Reduction of antibacterial activity of the insect hemolymph and degradation of Gm cecropin by GelE. The G. mellonella larvae were inoculated with live Escherichia coli K112 (5 x 103 cells/larva) as described by Kim et al. (27). After 24 h of further rearing, the hemolymph was collected and centrifuged in order to remove hemocytes and cell debris. Cell-free hemolymph (150 µl) was added to 150 µl of NaP buffer containing 5 µg of purified GelE or SprE or no proteases and incubated for 15 min at room temperature. Each sample was then mixed with an equal volume of 10% acetic acid. Each mixture was vigorously stirred overnight at room temperature and centrifuged for 30 min at 10,000 x g. The acid extract obtained as a supernatant was dried completely via vacuum centrifugation and resuspended in 0.01% acetic acid to a final concentration of 5 mg/ml. Samples were assessed for antibacterial activity against E. coli in a colony count assay, as described by Kim et al. (27). The experiments were repeated three times, and the mean values were used to construct a graph. In addition, the proteolytic activities of GelE and SprE against a Gm cecropin, namely, a cecropin-like antimicrobial peptide previously purified from G. mellonella hemolymph (27), was evaluated via tricine SDS-PAGE and high-performance liquid chromatography (HPLC). Synthetic Gm cecropin (20 µg) was incubated for 30 min with 2 µg of GelE or SprE in NaP buffer at room temperature. The mixtures were then subjected to tricine SDS-PAGE and C18 reverse-phase HPLC. The fractions were then eluted in a continuous 1.0%/min linear gradient of acetonitrile in 0.1% trifluoroacetic acid. Peptide fragments generated via GelE proteolysis were collected through the HPLC column and tested for their antibacterial properties against E. coli in radial diffusion assays (29).
Serum bactericidal and hemolytic assays. Fresh normal human serum (NHS) samples were collected from three healthy volunteers. NHS (15 µl) was mixed with 4 µg of GelE, SprE, heat-inactivated GelE (hGelE), or no protein in 30 µl of NaP buffer containing 170 mM NaCl and then incubated for 1 h at room temperature. Five microliters of washed mid-logarithmic-phase E. faecalis GM solution (4 x 104 CFU/ml) was then added to the mixture. After one additional hour of incubation at 37°C in a rotary incubator, 20 µl of the mixture was plated on tryptic soy agar. The resultant colonies were then counted after overnight incubation at 37°C. For controls, NHS and GelE were heat inactivated at 56°C for 30 min and at 75°C for 5 min, respectively. Data were expressed as the percent survival in each sample compared to that in heat-inactivated NHS (hNHS) [(number of CFU in sample/number of CFU in hNHS) x 100]. The hemolytic activity of NHS against rabbit erythrocytes was also determined using a modified version of the procedure described in the work of Jiang et al. (24). In brief, 20 µl of NHS was mixed with 70 µl of phosphate-buffered saline (PBS) containing 2 µg of GelE, SprE, or hGelE or no protein and incubated for 1 h at 37°C. Rabbit erythrocytes (106 cells) in 10 µl of PBS containing 1% bovine serum albumin were added to the mixture and incubated for an additional hour at 37°C. After 3 min of centrifugation at 10,000 x g, the optical density of the supernatant was measured at 405 nm. Twenty percent (vol/vol) hNHS in PBS was employed as a negative control sample. The percent lysis of rabbit erythrocytes in each sample was calculated according to the following equation: percent lysis = (A405 of sample A405 of PBS control)/(A405 of NHS sample A405 of PBS control) x 100. In addition, the inhibitory effect of GelE on the hemolytic activity of NHS was evaluated in a dose-dependent manner. In this assay, GelE in 90 µl of the incubation mixture (20 µl NHS plus 70 µl PBS) was twofold serially diluted in a concentration range from 0.05 to 0.4 µM. All experiments were repeated at least three times, and the mean values were used in the construction of graphs.
Detection of complement factor C3 deposition on the bacterial surface. Experiments were conducted in accordance with the method described previously in the work of Ren et al. (39). In brief, 25 µl of NHS was mixed with 42 µl of PBS containing 2 µg of GelE or SprE and incubated for 1 h in a rotary incubator at 37°C. The washed mid-logarithmic-phase E. faecalis GM solution (2 x 107 CFU/ml) (183 µl) was added to the sample and incubated for 10 additional minutes at 37°C. After three washings with PBS, the bacteria were resuspended in 30 µl of reducing SDS sample buffer (10 µl of 0.5 M Tris-HCl [pH 6.8] containing 10% SDS plus 20 µl of 60 mM dithiothreitol) and boiled for 5 min. The boiled sample was then centrifuged for 5 min at 3,000 rpm, and 10 µl of the supernatant was electrophoresed on an 8% SDS-PAGE gel. The gel was then transferred onto nitrocellulose membranes in Tris-glycine buffer (25 mM Tris, 192 mM glycine, 20% methanol, pH 8.3) for immunoblot analysis, which was conducted using a commercially available antibody (C7761; Sigma) against human complement component 3 (C3), in accordance with the methods of Towbin et al. (50). For a positive or negative control sample, 25 µl of NHS or hNHS, respectively, was incubated in 42 µl of PBS containing no proteases for 1 h, and each sample was subjected to the same procedure for immunoblot analysis as described above.
Proteolysis of human C3, C3b, and C3a by GelE. One microliter of NHS was added to 10 µl of NaP buffer containing 1 µg of GelE or SprE and then incubated for 20 min at room temperature. The sample was dried completely via vacuum centrifugation and resuspended in 50 µl of SDS-PAGE sample buffer. Five microliters was removed and electrophoresed on an 8% SDS-PAGE gel. In addition, 10 µl of log-phase E. faecalis GM solution (4 x 104 CFU/ml in PBS) was added to 190 µl TSB containing 60 µl of NHS. After incubation at 37°C for a predetermined time, the mixture was centrifuged for 10 min at 10,000 x g. Ten microliters of supernatant was removed and dried via vacuum centrifugation. It was then resuspended in 150 µl of SDS-PAGE sample buffer, and a 5-µl sample was subjected to SDS-PAGE. Two duplicate SDS-PAGE gels were employed for immunoblot analysis, which was conducted with an antibody against human C3. In order to determine the proteolytic activity of GelE against purified C3 components, 2 µg of commercially available C3 (C2910; Sigma), C3a (224881; Calbiochem, Germany), or C3b (204860; Calbiochem, Germany) was mixed with 10 µl of NaP buffer containing 1 µg of GelE. After 20 min of incubation at 37°C, the mixtures were subjected to 8% SDS-PAGE or 16.5% tricine SDS-PAGE.
Nucleotide sequence accession numbers. The full 16S rRNA sequence of E. faecalis GM was deposited in GenBank under accession no. EF120452. The nucleotide sequence of gelE from E. faecalis GM has been registered in GenBank under accession no. EF105504.
|
|
|---|
![]() View larger version (17K): [in a new window] |
FIG. 1. Survival of insects upon injection with E. faecalis GM or CS. Kaplan-Meier survival plots of G. mellonella injected with E. faecalis GM or ATCC 51299 (A) and CS of each strain (B). For a control, 5 µl of PBS was injected into each of the test larvae.
|
![]() View larger version (53K): [in a new window] |
FIG. 2. Purification of GelE from concentrated CS of E. faecalis GM. (A) Profile of Sephadex G-100 gel filtration chromatography. The optical density of each fraction was measured at 280 nm. The bar represents the range of fractions evidencing 100% mortality in our "infection and survival" test. (B) Anion-exchange chromatography as a final step in the purification of GelE. Two peaks, corresponding to gelatinase and serine protease, were indicated by GelE and SprE, respectively. (C) Tricine SDS-PAGE and immunoblot analysis. Left panel, a tricine SDS-PAGE gel stained with Coomassie blue; right panel, immunoblot analysis conducted with antiserum against GelE. Lane 1, pooled fractions (no. 26 to 46) from gel filtration chromatography, as indicated by the horizontal bar in panel A; lane 2, purified GelE; lane 3, purified SprE. (D) Kaplan-Meier survival plots of G. mellonella injected with differing quantities of purified GelE, ranging from 1 to 4 µg per larva, or SprE. Also, 5 µl of PBS was injected into the larvae as a control. (E) Detection of GelE in the concentrated CS of E. faecalis GM. Left panel, a 10% SDS-PAGE gel stained with Coomassie blue; right panel, immunoblot analysis using antiserum against GelE as a probe. Lane 1, purified GelE; lane 2, CS of E. faecalis ATCC 51299; lane 3, CS of E. faecalis GM.
|
![]() View larger version (41K): [in a new window] |
FIG. 3. Effects of GelE on antibacterial activity of G. mellonella hemolymph. (A) As shown in the acid extract sample of the immunized hemolymph incubated with GelE (GelE + IH), its antibacterial activity was significantly attenuated and close to that of nonimmunized hemolymph (NH). Error bars were too small to express. (B) A Coomassie blue-stained 16.5% tricine SDS-PAGE gel containing purified Gm cecropin and Gm cecropin treated with GelE or SprE. Lane M, standard marker; lane 1, 2 µg of Gm cecropin; lane 2, 2 µg of Gm cecropin treated with GelE; lane 3, 2 µg of Gm cecropin treated with SprE. (C) HPLC chromatograms of the GelE-induced digestion of Gm cecropin. Inset, radial diffusion assay for antibacterial activities of Fs, F1, and intact Gm cecropin (Cec).
|
![]() View larger version (17K): [in a new window] |
FIG. 4. Effect of GelE on complement activation in human seurm. (A) Role of GelE in complement-mediated killing of E. faecalis GM. The survival rate of E. faecalis GM in the PBS-hNHS sample was determined to be 100%, and the relative survival rate of each sample was measured. Error bars were too small to express. (B) Inhibitory effect of GelE on the complement-mediated lysis of rabbit erythrocytes. Lysis of erythrocytes in the PBS-NHS sample was determined to be 100%. (C) Dose-dependent effect of GelE on complement-mediated erythrocyte lysis. E. faecalis GM SprE was used as a negative control and had no effect on the complement-mediated lysis of erythrocytes (data not shown). Spontaneous erythrocyte lysis was <1% and was not represented.
|
, C3ß, and the
-chain fragment were identified in the protein samples separated from the bacterial surface. In contrast, C3 components deposited on the bacterial surface were not detected after the incubation of bacteria with hNHS or GelE-treated NHS. From this result, it was suggested that GelE inhibited the complement-mediated opsonization of bacteria.
![]() View larger version (59K): [in a new window] |
FIG. 5. Effect of GelE on cell surface deposition of C3. The protein samples on E. faecalis GM were detected via immunoblot analysis. The nitrocellulose membrane was probed with anti-C3 antibody, which had been diluted to a concentration of 1:1,000 in antibody solution (1% skim milk in Tris-buffered saline containing 0.05% Tween 20). The secondary antibody used in this experiment was horseradish peroxidase-conjugated goat anti-rabbit antibody, as appropriate, at a dilution of 1:8,000. One microgram of purified C3 was employed as a control. Lane 1, purified C3; lane 2, NHS incubated with PBS; lane 3, hNHS incubated with PBS; lane 4, NHS incubated with GelE; lane 5, NHS incubated with SprE. Arrows indicate the chain, ß chain, and -chain fragments of human C3.
|
and ß chains of C3 (115 and 75 kDa, respectively), the
-chain band disappeared from the gel upon the incubation of NHS with GelE (Fig. 6A, lane 2). In addition, we evaluated changes occurring in the C3 components of NHS incubated with E. faecalis GM (Fig. 6B). When E. faecalis GM (
400 CFU) was incubated for 6 h with 30% (vol/vol) NHS in TSB, the
and ß chains of C3 were found to have remained intact. In contrast, the
chain of C3 was not detected in the NHS samples incubated for 12 or 24 h. From Fig. 6A and B, it became evident that the
chain of C3 was destroyed via the action of GelE secreted from E. faecalis GM upon incubation for more than 12 h. Furthermore, in order to determine whether or not GelE directly hydrolyzed the components of C3, purified C3, C3a, or C3b was treated with GelE and subjected to SDS-PAGE. As a result, the band corresponding to the ß chain of C3 remained unaltered, as was also observed in the case of the NHS sample incubated with GelE. However, the
-chain band was observed at a position lower than that of the intact C3 (Fig. 7A), which appeared to be equivalent to the position of the C3b
chain without C3a, which is an N-terminal 9-kDa component of the
chain of C3 (Fig. 7C). When the
chain generated from C3 treated with GelE was transferred to a polyvinylidene difluoride membrane and subjected to Edman degradation analysis, its N-terminal 10-amino-acid sequence was identified to be LDEDIIAEEN. Accordingly, it was concluded that GelE cleaved the peptide bond between Asn and Leu residues, which is close to the scissile bond of C3 convertase (Fig. 7B). In addition, C3a was determined to be further degraded by GelE, as it was not detected in the SDS-PAGE gel after incubation with GelE (Fig. 7D).
![]() View larger version (39K): [in a new window] |
FIG. 6. Degradation of complement factor C3 chain by GelE, as determined via SDS-PAGE. (A) Proteolysis of the C3 chain in NHS by GelE. Left panel, 8% SDS-PAGE gel conducted with NHS; right panel, immunoblot analysis. Lane M, molecular mass marker; lane 1, NHS incubated with PBS; lane 2, NHS incubated with GelE; lane 3, NHS incubated with SprE. Arrows indicate the intact and ß chains of C3 present in NHS. (B) Change in the C3 chain in NHS by E. faecalis GM. Equal volumes of the mixtures were removed and subjected to SDS-PAGE and immunoblot analysis. Upper panel, an SDS-PAGE gel; lower panel, immunoblot analysis. Lane 1, NHS incubated with PBS; lane 2, NHS incubated with E. faecalis GM for 6 h; lane 3, NHS incubated with E. faecalis GM for 12 h; lane 4, NHS incubated with E. faecalis GM for 24 h.
|
![]() View larger version (47K): [in a new window] |
FIG. 7. Proteolysis of complement factor C3 and C3a by GelE. (A) SDS-PAGE performed with purified C3. Lane M, molecular mass marker; lane 1, C3 incubated with PBS; lane 2, C3 incubated with GelE. (B) Schematic view of C3 cleavage by GelE. The cleavage sites of C3 chain by C3 convertase or GelE are marked by arrows, and the vertical bar represents a disulfide bond between the C3 chain and C3 ß chain. (C) SDS-PAGE performed with purified C3b. Lane M, molecular mass marker; lane 1, C3b incubated with PBS; lane 2, C3b incubated with GelE. (D) Tricine SDS-PAGE performed with purified C3a. Lane M, molecular mass marker; lane 1, C3a incubated with PBS; lane 2, C3a incubated with GelE. The gels were stained with Coomassie blue.
|
|
|
|---|
In this study, we purified two proteases (GelE and SprE) secreted by E. faecalis GM, which was isolated from the cadavers of G. mellonella larvae. Several proteinases secreted from a variety of pathogenic bacteria were previously shown to be capable of degrading an antimicrobial peptide such as LL-37 and abolishing its activity (43), which indicated that proteolytic degradation of an antimicrobial peptide might be a common virulence mechanism. Accordingly, we first evaluated the virulence effects of GelE and SprE on antimicrobial peptides and on the complement system, which were principally responsible for the clearance of invading microbes at the early phase of microbial infection from insect hemolymph and from human blood, respectively. In several animal infection models, E. faecalis GelE and SprE were identified as critical virulence factors of E. faecalis, although the mechanisms underlying their virulence remain to be fully elucidated. GelE/SprE-producing E. faecalis was shown, in a mouse peritonitis model, to elicit increased mortality compared to the GelE/SprE-defective mutant (47). Similarly, E. faecalis GelE and SprE were determined to contribute in concert to pathogenesis in a rabbit endophthalmitis model (11) and a C. elegans-killing model (46). In particular, Creti et al. (6) reported that when a collection of E. faecalis strains from clinical isolates was screened for the presence of virulence factor genes, the GelE gene (gelE) was found to be the most common factor. It was also previously determined that E. faecalis expressed gelE at the second highest level among several enterococcal virulence genes upon culture in human serum (44). In parallel with these previous results, our data (Fig. 3) showed that E. faecalis GelE negated an inducible antimicrobial activity of the G. mellonella hemolymph, which was attributed to the degradation of Gm cecropin by GelE. Collectively, these findings suggested that the extracellular GelE protein of E. faecalis may perform a critical role in overcoming the immune systems inherent to human serum, thereby perpetuating bacterial survival in vivo. In order to confirm this hypothesis, we evaluated the effects of E. faecalis GelE on the complement system of human serum.
Complement activation, via the classical, lectin, or alternative pathway, frequently results in the activation of C3, which results in the generation of C3b and iC3b for the opsonization of the target and consequently causes the formation of the membrane attack complex (MAC). In order to resist opsonophagocytosis and MAC-mediated killing, pathogenic microbes have developed an array of virulence mechanisms. Three groups of streptococci have been the most extensively studied with regard to bacterial complement resistance mechanisms (22). Streptococcus pyogenes and S. agalactiae evade complement attack via the acquisition of host regulators of complement amplification, including factor H and C4bp (20, 49). In addition, S. pyogenes secretes streptococcal inhibitor of complement, which binds to the host complement regulator clusterin and thereby inhibits the reactive hemolysis of guinea pig erythrocytes resultant from complement activation (1, 48). Pneumococcal surface protein A (PspA) has also been identified as a virulence factor of S. pneumoniae, which also appears to function as a complement inhibitor (39). PspA was demonstrated, using mouse models, to reduce the quantity of C3b deposited onto the surfaces of pneumococci (39). Accordingly, PspA has been suggested to affect complement activation and to inhibit the formation of C3 convertase (51). However, the precise mechanism employed by PspA in the inhibition of complement activation remains to be elucidated. Unlike streptococcal virulence factors, E. faecalis GelE exerts an inhibitory effect against the complement system via its proteolytic properties. Thus far, GelE has been shown to be capable of degrading several substrates, including gelatin, insulin B chain, human endothelin, collagen, and several bioactive peptides (30). However, the hydrolysis of an antimicrobial peptide and C3a by E. faecalis GelE is a novel finding in this study. C3a, also referred to as anaphylatoxin, has been reported to perform an important function in host defense against microbial infections as well as in immune regulation. A variety of the functions of a host of immune cells, including macrophages, eosinophils, basophils, mast cells, and B lymphocytes, have been demonstrated to be modulated by C3a (28). Interestingly, it was recently shown that C3a and C3a-derived peptides also evidenced antibacterial properties and were capable of killing several bacteria, as has been observed with many other antimicrobial peptides (36). Therefore, the degradation of C3a by GelE permitted us to postulate that GelE may contribute to the paralysis of a variety of C3a-mediated immune reactions occurring in human blood. Also, this finding emphasized the importance of GelE as a virulence factor of E. faecalis. However, the
chain of the purified C3b was not affected by GelE (Fig. 7C), although the
chain of C3 in NHS was degraded completely upon incubation with NHS and GelE (Fig. 6A). According to these data, we now surmise that the
chain of C3b may be destroyed via the action of an as-yet-unknown factor in human serum, which is apparently activated by GelE.
In conclusion, we have demonstrated the virulence effects of E. faecalis GelE on the immune systems of insects and the complement system inherent to human serum. GelE directly hydrolyzed a cecropin-like antimicrobial peptide and C3a. It was also determined to inhibit C3b-mediated immune reactions (opsonization and MAC formation) via the stimulation of the degradation of the
chain of C3b in human serum. In contrast, extracellular SprE, which has also been considered a putative virulence factor of E. faecalis, did not affect the immune systems evaluated in the present study.
Published ahead of print on 29 January 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»